Blue Cross and Blue Shield of North Carolina does not cover Wegovy as a standard benefit on its commercial plans. The drug sits on the insurer’s list of weight-loss medications excluded from standard coverage, so most members who want Wegovy for weight management will need to look at manufacturer savings, an appeal, or a self-funded employer plan that has opted into a separate GLP-1 program.1Blue Cross NC. Non-Formulary Drugs
Why Standard Plans Exclude Wegovy
Blue Cross NC’s formulary places Wegovy alongside Zepbound, Saxenda, Contrave, and Qsymia in the “not covered as a standard benefit” category.1Blue Cross NC. Non-Formulary Drugs ACA marketplace formulary documents state that “coverage of drugs used for weight loss may be subject to benefit exclusion based on member benefit.”2MyPrime. Blue Cross NC Essential QHP-S 4-Tier Formulary
This is a benefit exclusion, not a prior authorization step. That distinction matters. A prior authorization can be satisfied with the right paperwork; a benefit exclusion means the drug is not a covered service under the plan at all. The list price sits at roughly $1,350 for a 28-day supply, or about $16,200 a year.3GoodRx. Wegovy for Weight Loss Cost and Coverage
The Self-Funded Employer Exception: The Vida GLP-1 Program
Effective January 1, 2025, Blue Cross NC launched a “GLP-1 for Weight Management” program powered by Vida Health. It is available only to Administrative Services Only (ASO) plans, meaning self-funded employer plans that use Blue Cross NC to administer benefits while the employer decides what to cover.4Blue Cross NC. New Expanded Member Programs
Clinical criteria track the FDA’s indication for anti-obesity medication:
- BMI of 30 or above without weight-related comorbidities, or
- BMI of 27 or above with weight-related comorbidities such as high blood pressure, high cholesterol, or type 2 diabetes.
Members must also be enrolled in a Blue Cross NC pharmacy plan. The program pairs the medication with a registered-dietitian-led coaching component built on cognitive behavioral therapy principles. Members already on a GLP-1 keep the remainder of their existing prior authorization if they enroll.4Blue Cross NC. New Expanded Member Programs
Not every ASO employer participates. Call the number on the back of your ID card to confirm whether your specific plan has opted in.
If You Have Blue Cross NC Medicare Advantage
Standard Medicare Part D does not cover weight-loss drugs, and Blue Cross NC’s 2026 Medicare Advantage formulary does not list Wegovy.5Blue Cross NC. Blue Medicare Choice HMO Formulary That changes on July 1, 2026, when the federal Medicare GLP-1 Bridge program takes effect. The Bridge is a temporary CMS program that provides Wegovy (injection and tablet), Zepbound (KwikPen), and Foundayo outside the normal Part D benefit, and it runs through December 31, 2027. Anyone enrolled in a Part D plan or a Medicare Advantage prescription drug plan, including Blue Cross NC Medicare members, is eligible.6CMS. Medicare GLP-1 Bridge
Eligibility depends on BMI and specific conditions:
- BMI of 35 or higher: no additional diagnosis required.
- BMI of 30 or higher: with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease (stage 3a or above).
- BMI of 27 or higher: with pre-diabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.
The copay is a flat $50 for a 30-day supply. It does not count toward the Part D deductible or out-of-pocket maximum, and Extra Help subsidies cannot reduce it.7Medicare.gov. Weight Loss Drugs Prior authorization goes through a central processor (Humana handles Bridge claims), not the member’s own Part D plan.8CMS. Medicare GLP-1 Bridge Information for Providers
A Note for State Employees and Retirees
The North Carolina State Health Plan is not Blue Cross NC commercial insurance, even though Blue Cross NC administers it. The State Health Plan stopped covering Wegovy and other GLP-1 weight-loss drugs effective April 1, 2024, after the Board of Trustees voted 4 to 3 to end the benefit. GLP-1s for diabetes remain covered.9WRAL. NC State Health Plan Phases Out Weight-Loss Drug Coverage As of mid-2026, coverage has not been restored. State Treasurer Brad Briner has said the upcoming state budget is unlikely to include the roughly $100 million needed to bring it back, though the plan is negotiating directly with manufacturers on price.10WRAL. North Carolina Expected Budget Won’t Restore Weight-Loss Coverage
What To Do if Coverage Is Denied
Confirm What Your Specific Plan Says
Coverage varies plan by plan. An employer-sponsored plan may have opted into the Vida program or written weight-loss drugs into its own benefits. The first step is a call to member services using the number on your ID card, asking specifically whether Wegovy is covered under your plan for weight management.
File an Appeal
If your plan has any pathway to coverage and your claim was still denied, you or your doctor can appeal. Start by reviewing the Explanation of Benefits to identify the exact reason for the denial, then submit a written appeal within six months of the denial notice. Useful documentation includes your current BMI, records of prior weight-loss treatments that did not work, any weight-related conditions, and a medical necessity letter from your provider. About 44% of insurance denials are successfully appealed, according to 2023 data.11Medical News Today. How To Appeal a Wegovy Denial
One angle worth considering: Wegovy also carries an FDA-approved indication for reducing the risk of major cardiovascular events in adults with established heart disease who have obesity or overweight. If that fits your situation, an appeal framed around cardiovascular risk reduction rather than weight loss can sometimes reach a different result even under a plan that excludes weight-loss drugs.12Novo Nordisk. Wegovy Denials and Appeals Guide
Ask Your Employer To Add the Benefit
If your plan is employer-sponsored, especially a self-funded one, your HR or benefits department can add anti-obesity medications to the plan design. Novo Nordisk offers a sample letter a provider can submit to make that request.13Wegovy. What To Pay for Wegovy
Paying Out of Pocket
Several routes bring the cost below the roughly $1,350 list price:
- Manufacturer copay card. Patients with commercial insurance, even insurance that doesn’t cover Wegovy, may pay as little as $25 per month, with a maximum savings of $100 per month. Members of government plans are not eligible.13Wegovy. What To Pay for Wegovy
- Self-pay pricing through NovoCare. The 1.5 mg and 4 mg doses run $149 per month through August 31, 2026 (the 4 mg dose then rises to $199). New patients on lower doses can get an introductory rate of $199 per month for the first two months. The standard self-pay price after introductory periods is $349 per month for injections.14NovoCare. Savings and Support
- Patient Assistance Program. Uninsured patients with household income at or below 400% of the federal poverty level may qualify for free medication. Applicants must be U.S. citizens or legal residents and cannot have private insurance or qualify for Medicaid or VA benefits.15NovoCare. Patient Assistance Program
- HSA and FSA funds. Weight-loss medications can be eligible expenses under a Health Savings Account or Flexible Spending Account, letting you pay with pre-tax dollars.
To enroll in the savings card program, text “SAVE” to 83757 or visit the NovoCare website. For questions about savings offers, call 1-888-793-1218.13Wegovy. What To Pay for Wegovy